FAM111A

Chr 11AD

FAM111 trypsin like peptidase A

Also known as: GCLEB, KCS2

The protein encoded by this gene is cell-cycle regulated, and has nuclear localization. The C-terminal half of the protein shares homology with trypsin-like peptidases and it contains a PCNA-interacting peptide (PIP) box, that is necessary for its co-localization with proliferating cell nuclear antigen (PCNA). Reduced expression of this gene resulted in DNA replication defects, consistent with the demonstrated role for this gene in Simian Virus 40 (SV40) viral replication. Mutations in this gene have been associated with Kenny-Caffey syndrome (KCS) type 2 and the more severe osteocraniostenosis (OCS, also known as Gracile Bone Dysplasia), both characterized by short stature, hypoparathyroidism, bone development abnormalities, and hypocalcemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]

Primary Disease Associations & Inheritance

Gracile bone dysplasiaMIM #602361
AD
Kenny-Caffey syndrome, type 2MIM #127000
AD
365
ClinVar variants
15
Pathogenic / LP
0.00
pLI score
0
Active trials
Clinical SummaryFAM111A
🧬
Gene-Disease Validity (ClinGen)
FAM111A-related skeletal dysplasia · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
15 Pathogenic / Likely Pathogenic· 197 VUS of 365 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
1.95LOEUF
pLI 0.002
Z-score -1.21
OE 2.09 (0.661.95)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
-0.02Z-score
OE missense 1.00 (0.921.10)
324 obs / 322.9 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.2.09 (0.661.95)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.1.00 (0.921.10)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.95
01.21.6
LoF obs/exp: 3 / 1.4Missense obs/exp: 324 / 322.9Syn Z: 0.41

ClinVar Variant Classifications

365 submitted variants in ClinVar

Classification Summary

Pathogenic6
Likely Pathogenic9
VUS197
Likely Benign99
Benign35
Conflicting19
6
Pathogenic
9
Likely Pathogenic
197
VUS
99
Likely Benign
35
Benign
19
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
1
5
0
6
Likely Pathogenic
0
5
4
0
9
VUS
8
179
8
2
197
Likely Benign
7
23
8
61
99
Benign
0
18
6
11
35
Conflicting
19
Total152263174365

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

FAM111A · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

FAM111A-related Kenny-Caffey syndrome

definitive
ADGain Of FunctionAltered Gene Product Structure
Dev. DisordersEyeSkeletal
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

Gracile bone dysplasia

MIM #602361

Molecular basis of disorder known

Autosomal dominant

Kenny-Caffey syndrome, type 2

MIM #127000

Molecular basis of disorder known

Autosomal dominant
📖
GeneReview available — FAM111A
Authoritative clinical overview · NCBI Bookshelf · Recommended first read
Open GeneReview ↗
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Expanding the Phenotypic Spectrum of Kenny-Caffey Syndrome.
Schigt H et al.·J Clin Endocrinol Metab
2023
[Kenny-Caffey syndrome and its related syndromes].
Isojima T et al.·Nihon Rinsho
2015Review
Top 10 resultsSearch PubMed ↗

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →